What is Sihuan Pharmaceutical Holdings Group Buyback Yield %?
Sihuan Pharmaceutical Holdings GroupSHPHF 52 Buyback Yield % is 2.62 as of Jul. 03, 2026, which is 309% above its 10-year median of 0.64. GuruFocus rates SHPHF with a GF Scoreâ„¢ of 52/100 and a GF Valueâ„¢ of $0.17 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 292 Drug Manufacturers companies, Sihuan Pharmaceutical Holdings Group ranks better than 92.47% on this metric.
Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sihuan Pharmaceutical Holdings Group Buyback Yield % Chart
For the Drug Manufacturers - Specialty & Generic subindustry, Sihuan Pharmaceutical Holdings Group's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sihuan Pharmaceutical Holdings Group Buyback Yield % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Sihuan Pharmaceutical Holdings Group's Buyback Yield % distribution charts can be found below:
* The bar in red indicates where Sihuan Pharmaceutical Holdings Group's Buyback Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sihuan Pharmaceutical Holdings Group (SHPHF) has a Buyback Yield % of 2.62 as of Jul. 03, 2026. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Sihuan Pharmaceutical Holdings Group and its competitors. This is 309% above median its historical median of 0.64. Over the past decade, Sihuan Pharmaceutical Holdings Group's Buyback Yield % has ranged from 0.06 to 6.70. According to the industry distribution chart, Sihuan Pharmaceutical Holdings Group ranks #22 out of 292 companies in the Drug Manufacturers industry, placing it in the top 7.5%.
Is Sihuan Pharmaceutical Holdings Group's Buyback Yield % too high?
Sihuan Pharmaceutical Holdings Group's current Buyback Yield % of 2.62 is 309% above median its 10-year median of 0.64. Over the past 10 years, this metric has ranged from a low of 0.06 to a high of 6.70. Based on the distribution chart, Sihuan Pharmaceutical Holdings Group ranks #22 out of 292 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Sihuan Pharmaceutical Holdings Group has a GF Score™ of 52/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Sihuan Pharmaceutical Holdings Group's Buyback Yield % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Sihuan Pharmaceutical Holdings Group ranks #22 out of 292 companies for Buyback Yield %. This places Sihuan Pharmaceutical Holdings Group in the top 8% of its industry — outperforming the majority of peers. Historically, Sihuan Pharmaceutical Holdings Group's own Buyback Yield % has ranged from 0.06 to 6.70 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Buyback Yield % for a Drug Manufacturers company?
A good Buyback Yield % depends on the Drug Manufacturers industry context. However, Buyback Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Buyback Yield % mean?
A high Buyback Yield % can signal that a stock is expensive relative to its fundamentals. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Sihuan Pharmaceutical Holdings Group and its competitors. Sihuan Pharmaceutical Holdings Group's current Buyback Yield % is 2.62, which is 309% above median its own 10-year median of 0.64. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sihuan Pharmaceutical Holdings Group stock overvalued right now?
Based on GuruFocus' analysis, Sihuan Pharmaceutical Holdings Group (SHPHF) is currently considered Modestly Undervalued. The stock's GF Value™ is $0.17, compared to a current price of $0.13 — trading 23.7% below its estimated fair value. The current Buyback Yield % is 2.62, which is 309% above median its 10-year median of 0.64. Sihuan Pharmaceutical Holdings Group's overall GF Score™ is 52/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Buyback Yield % calculated?
Buyback Yield % is calculated from a company's financial statements. For Sihuan Pharmaceutical Holdings Group (SHPHF), the current Buyback Yield % is 2.62 as of Jul. 03, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Sihuan Pharmaceutical Holdings Group (SHPHF) Overvalued in 2026?
Based on GuruFocus' analysis, Sihuan Pharmaceutical Holdings Group stock appears to be undervalued.
The current stock price of $0.13 is trading 23.7% below its estimated GF Value™ of $0.17.
GuruFocus considers Sihuan Pharmaceutical Holdings Group to be Modestly Undervalued.
Key valuation signals for SHPHF:
Buyback Yield %: 2.62 (309% above median its 10-year median of 0.64)
GF Value™: $0.17 vs. price of $0.13 (23.7% below fair value)
No single metric tells the full story. See the SHPHF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Sihuan Pharmaceutical Holdings Group Business Description
Sihuan Pharmaceutical Holdings Group Ltd is an investment holding company. Along with its subsidiaries, the company is engaged in the research & development and the manufacture & sale of pharmaceutical products. Its portfolio comprises products for diseases related to the cardio-cerebral vascular (CCV) system, Respiratory, Neurology, and others. The group has three reportable segments: the medical aesthetic products segment, including the filling, shaping, supporting, supplementing, optoelectronic device, body sculpturing, skincare, and others; the innovative medicine and other medicine segment; and the generic medicine segment, which generates key revenue. Geographically, the company generates a majority of its revenue from Mainland China and the rest from the United States.
52GF Score
Get the complete analysis for SHPHF
Buyback Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHPHF has been successfully added to your 
